Since no report provides a general assessment of IL-1 concentrations in COVID-19, we examined studies that quantified IL-1 in plasma or serum using enzyme-linked immunosorbent assay (ELISA) or bead-based immunoassay technologies. This evidence concerns the gene IL1B and COVID-19.